Epidemiological and clinical criteria for the diagnosis of cutaneous leishmaniasis in Tunisia

##plugins.themes.academic_pro.article.main##

Karim Aoun
Fida Maatallah
Wafa Aissi
Olfa Souissi
Nada Boulehmi
Emna Siala
Rym Ben Abdallah
Aïda Bouratbine

Abstract

Introduction: Biological confirmation of cutaneous leishmaniosis (CL) and identification of species involved are not always available. Zoonotic CL (ZCL) in the center-south and sporadic CL (SCL) in the north are the main forms of the disease in Tunisia. They have recently spread and are now coexisting in several regions.


Aim: To establish simple epidemiological and clinical criteria to improve CL diagnosis and to assess the CL form.


Methods: Dermal smears of 227 patients suspected of CL were examined by microscopy and then scrapped, the DNAs were extracted and tested by PCR. Epidemiological and clinical data were anonymously collected.


Results: The diagnosis of CL was confirmed by at least one biological test in 76 patients infected in the center-south (ZCL) and 24 patients infected in the north (SCL). CL cases consulted mainly between october and january (66.3% versus 46%; p=0.003). Their lesions were more multiple (48.5% versus 32.5%; p=0.002).


Compared to SCL cases, a higher proportion of ZCL cases consulted between october and january (73.7% versus 45.8%; p<0.01). Their number of lesions was higher (3.3±0.4 versus 1.2±0.1; p<0.0001), with a preferential limb location (80.3% versus 25%; p<0.001). Lesions of SCL cases were older (6±1.2 versus 2.2±0.2 months; p<0.001) with less ulcerative-crusted presentation (41.6% versus 77.6%; p=0.009).


Conclusion: Some easy to collect epidemiological and clinical data would be suggestive of the diagnosis and the form of CL. Collecting these data could improve surveillance of the disease and case management especially in rural areas with few diagnostic facilities.

Keywords:

Cutaneous leishmaniasis, Epidemiological data, Clinical symptoms, Diagnosis, Tunisia

##plugins.themes.academic_pro.article.details##

References

  1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS One. 2012;7:e35671..
  2. Aoun K, Bouratbine A. Cutaneous Leishmaniasis in North Africa: a review. Parasite. 2014;21:14.
  3. Ministère de la Santé, Tunisie. Le Bulletin Epidémiologique de la Direction des Soins de Santé de Base n01/2015 [En ligne]. Mar 2015 [Consulté le 10 Juil 2024]; [8 pages]. Consultable à l’URL:
  4. Chahed M K, Bellali H,Ben Jemaa S,Bellaj T. Psychological and Psychosocial Consequences of Zoonotic Cutaneous Leishmaniasis among Women in Tunisia: Preliminary Findings from an Exploratory Study. PLoS Negl Trop Dis. 10(10): e0005090.
  5. Aoun K, Tebrouri M, Ben Abdallah R, Bellali H, Souissi O, Bouratbine A. Contribution de la PCR en temps réel dans le diagnostic biologique de la leishmaniose cutanée : expérience de l’institut Pasteur de Tunis. Bull Soc Pathol Exot. 2020;113(5):251–3.
  6. Reimão JQ, Coser EM, Lee MR, Coelho AC. Laboratory diagnosis of cutaneous and visceral leishmaniasis: current and future methods. Microorganisms. 2020;8(11):1632.
  7. Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63(12):e202–64.
  8. Bouratbine A, Aoun K, Ben-Abda I, Bousslimi N, Raouane M, Ben-Alaya-Bouafif N. Epidemiologic and clinical features of cutaneous leishmaniasis in southeastern Tunisia. Am J Trop Med Hyg. 2010;83:1034-9.
  9. Ben Ismail R, Ben Rachid M. Epidémiologie des leishmanioses en Tunisie. In: Maladies Tropicales Transmissibles. Paris : Aupelf-Uref, John Libbey Eurotex ; 1989. 73–80.
  10. Kallel K, Haouas N, Pratlong F, Kaouech E, Belhadj S, Anane S, et al. La leishmaniose cutanée due à Leishmania infantum MON-24 en Tunisie : extension du foyer vers le centre du pays. Bull Soc Pathol Exot. 2008;101(1): 30-1.
  11. Buffet PA, Rosenthal É, Gangneux J-P, Lightburne E, Couppié P, Morizot G, et al. Traitement des leishmanioses en France : proposition d’un référentiel consensuel. La Presse Médicale 2011;40:173–84.
  12. Al-Jawabreh A, Schoenian G, Hamarsheh O, Presber W. Clinical diagnosis of cutaneous leishmaniasis: A comparison study between standardized graded direct microscopy and ITS1-PCR of Giemsa-stained smears. Acta Tropica. 2006;99:55–61.
  13. Aoun K, Amri F, Chouihi E, Haouas N, Bedoui K, Benikhlef R, et al. Epidémiologie de Leishmania (L.) infantum, L. major et L. killicki en Tunisie: résultats et analyse de l’identification de 226 isolats humains et canins et revue de la littérature. Bull Soc Pathol Exot. 2008;101(4):323–8.
  14. Aoun K, Ben Abda I, Bousslimi N, Bettaieb J, Siala E, Ben Abdallah R, et al. Caractérisation comparative des trois formes de leishmaniose cutanée endémiques en Tunisie. Annales de Dermatologie et de Vénéréologie. 2012;139:452-8.
  15. Chraiet-Rezgani K, Bouafif-Ben Alaya N, Habboul Z, Hajjej Y, Aoun K. Aspects épidémiologiques et cliniques de la leishmaniose cutanée à Kairouan-Tunisie et particularités chez l'enfant. Bull Soc PatholExot. 2016;109:80-3.
  16. Kouki C, Cheikhrouhou F, Sellami K, Amamou S, kammoun N, Bahloul E, et al. Formes cliniques de la leishmaniose cutanée : étude de 2800 cas du sud tunisien. Annales de Dermatologie et de Vénéréologie – FMC. 2021;1:A251.
  17. Chelbi I, Zhioua E. Biology of Phlebotomus papatasi (Diptera: Psychodidae) in the laboratory. Journal of Medical Entomology. 2007;44:597-600.
  18. Ghrab J, Rhim A, Bach-Hamba D, Chahed MK, Aoun K, Nouira S, et al. Phlebotominae (Diptera: Psychodidae) of human leishmaniosis sites in Tunisia. Parasite. mars 2006;13(1):23‑33.
  19. Aoun K, Kalboussi Y, Ben Sghaier I, Souissi O, Hammami H, Bellali H, et al. Assessment of incubation period of cutaneous leishmaniasis due to Leishmania major in Tunisia. Am J Trop Med Hyg. 2020;103:1934-7.
  20. Pearson RD, Sousa AQ. Clinical spectrum of Leishmaniasis. Clin Infect Dis. 1996;22:1-13.
  21. Bailey MS, Lockwood DNJ. Cutaneous leishmaniasis. Clinics in Dermatology 2007;25:203-11.
  22. Masmoudi A, Ayadi N, Boudaya S, Meziou TJ, Mseddi M, Marrekchi S, et al. Polymorphisme clinique de la leishmaniose cutanée du centre et sud tunisien. Bull Soc PatholExot. 2007;100(1):36-40.
  23. Killick-Kendrick R. Phlebotomine vectors of the leishmaniases: a review. Med VetEntomol. 1990;4:1-24.
  24. Bachi F. Aspects épidémiologiques et cliniques des leishmanioses en Algérie. La Lettre de l’infectiologue. 2006;21(1):9-15.
  25. Chiheb S, Slaoui W, Mouttaqui T, Riyad M, Benchikhi H. [Cutaneous leishmaniasis by Leishmania major and Leishmania tropica in Morocco: comparative epidemioclinical aspects of 268 cases]. Pan Afr Med J. 2014;19:160.
  26. Benikhlef R, Aoun K, Boudrissa A, Ben Abid M, Cherif K, Aissi W, et al. Cutaneous leishmaniasis in Algeria; highlight on the focus of M’Sila. Microorganisms. 2021;9(5):962.
  27. OMS. Recognizing neglected tropical diseases through changes on the skin. Geneva. 2018 ; 49 p.